|
|
16597 North 92nd Street, Suite 101 Scottsdale, AZ 85260 USA phone:480.502.3661 fax:480.502.3670
|
|
| Symbol |
Private |
| Founded |
2005 |
| Employees |
40 |
|
|
| www.cayennemedical.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Soft tissue reconstruction segment of the sports medicine market. |
 |
| Management |
| James W. Hart, President, Chief Executive Officer and Chairman; Daniel P. Murray, Chief Financial Officer; Derek J. Harper, Vice President of Research and Development; Tim S. Nash, Vice President; Kereshmeh Shahriari, Director of Quality Assurance and Regulatory Affairs |
| |
|
|
| |
|
| Keywords |
| sports, knee, orthopedics, advamed, anterior cruciate ligament, ACL, joint, Arizona, AperFix |
|
|
|
| Description |
|
Cayenne Medical specializes in design and manufacture of femoral and tibial implants to address clinical needs in knee anterior cruciate ligament (ACL) reconstruction. |
 |
| Products / Services |
The AperFix System is a soft tissue aperture fixation system for anterior cruciate ligament (ACL) reconstruction using the hamstring and other soft tissue grafts which addresses issues of fixation strength and postoperative laxity which are often problematic with other fixation devices.
|
 |
| Technology / Differentiation |
| The AperFix System consists of femoral and tibial implants made from PEEK, a polyetheretherketone material with well-documented strength and rigidity, and the ability to pass x-rays and other forms of radiant energy with little attenuation. |
 |
| Market / Customers |
The Anterior Cruciate Ligament (ACL) is the primary stabilizer of the knee. If it is torn, the person will feel a pop and experiences immediate pain and swelling, and if not repaired, the patient will have recurrent instability of the knee. Over time, this can cause long-term damage. According to the American Academy of Orthopaedic Surgeons, approximately 80,000 people each year, mostly ages 15 to 25, tear their ACL.
|
 |
| Status |
| Cayenne has received 510(k) market clearance from the US Food and Drug Administration for the AperFix System and the product is now available for clinical use in the U.S. |
 |
|
|
|
|
|
|